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Abstract Pseudomonas aeruginosa is a nosocomial pathogen, which, due to its
inherent and acquired resistance to a wide range of antibiotics, causes high mor-
tality rates. Therefore, rapid detection of the bacterium with high speciﬁcity and
sensitivity plays a critical role in the control of the pathogenic bacterium. The aim
of this study was to evaluate the accuracy and speciﬁcity of a prompt detection of
the bacterium based on a triplex polymerase chain reaction that ampliﬁes the lasI,
lasR and gyrB genes.
For this purpose, 30 clinical isolates of P. aeruginosa and 30 wound biopsy sam-
ples were retrieved from clinical diagnostic laboratories. After the extraction of the
chromosomal DNA, the desired genes were ampliﬁed using uniplex and triplex PCR
with appropriate primers. The speciﬁcity of the primers was evaluated by a com-
parison of the PCR results for P. aeruginosa clinical samples and non-Pseudomonas
species control samples. The sensitivity of the primers was determined using a serial
dilution of the genomic DNA template (100 ng to 100 fg) and by a comparison of the
PCR and bacterial culture results.
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seudomonas aeruginosa is one of the most impor-
ant and opportunistic pathogens that causes a
igh rate of mortality and morbidity in hospitalized
atients with compromised immune systems [1,2].
seudomonas infections are generally treated by
ntibiotics; however, unfortunately, in hospitalized
atients, these infections are becoming more dif-
cult to be treated, speciﬁcally because of the
ncreasing number of antibiotic-resistant strains. In
ecent years, infections caused by this bacterium
re one of the major problems in hospitals and are
ssociated with high rates of mortality, which range
rom 18% to 61% [3—7]. Thus, early diagnosis and
roper medical treatments are the best strategies
or ﬁghting against these infections [8]. In most
aboratories, the detection of P. aeruginosa is still
ccomplished by microbiological culture and bio-
hemical tests. Although a comparative study has
hown that these methods contain reliable detec-
ion results, they are time-consuming and require
everal days to be completed [9,10]. Studies have
hown that inappropriate initial antimicrobial ther-
pies are associated with adverse outcomes for
nfection treatments. Conversely, false detection
an result in the administration of ineffective
ntimicrobial therapies during the ﬁrst 48—72 h
11,12]. Moreover, in some cases in which the bac-
erial count is low, especially in antibiotic-treated
atients, false-negative results can be achieved
n routine laboratory tests. Thus, access to rapid
nd speciﬁc methods that have a high sensitiv-
ty is of a great importance. In recent decades,
he detection and identiﬁcation of P. aeruginosa
n clinical samples by polymerase chain reaction
PCR) has been increased substantially [13,14].
ince 1992, when McIntosh et al. reported PCR
etection of P. aeruginosa for the ﬁrst time, multi-
le genes have been reported as PCR targets for
he identiﬁcation of this bacterium [13,15—18].
fterward, various studies have shown that these
enes do not have complete sensitivity or speciﬁcity
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triplex PCR assay was positive for all of the samples
iﬁcations were negative for non-Pseudomonas species.
−5 diluted genomic DNA from P. aeruginosa (10 pg and
s positive for the Las and gyrB genes in all of the samples,
results, the designed primers can be used for the rapid,
sis of P. aeruginosa in a triplex PCR assay.
ziz University for Health Sciences. Published by Elsevier
or bacterial detection and, thus, have false-
egative and false-positive results. It should be
oted that P. aeruginosa’s genome has a highly
olymorphic nature, which can inﬂuence the reli-
bility and speciﬁcity of the PCR. Therefore, the
se of a single gene target could lead to unexpected
rrors, including cross reactions with other bac-
erial species and false-negative or false-positive
esults, and a highly stringent and distinctive PCR
ssay is needed [19,20]. In this study, we have
eveloped and validated a triplex PCR assay for
he detection of P. aeruginosa using three differ-
nt genes, including the lasI, lasR, and gyrB genes.
t has been reported that the gyrB gene, which
ncodes the subunit B of DNA gyrase, is a reli-
ble PCR target for P. aeruginosa detection [21],
hile the lasI and lasR genes are essential quo-
um sensing (QS) genes of the bacterium. According
o studies, QS is necessary for the development of
nfection by P. aeruginosa, and the QS genes are
xclusive and conserved for each bacterial species
22—25]. Thus, given the importance of these genes
n the pathogenicity of P. aeruginosa, las genes
an be used for the detection of P. aeruginosa
n the PCR assay. Because some studies have
hown few clinical isolates with quorum sensing-
eﬁcient systems [26], we include the gyrB gene
o reduce false-negative results in the detection
rocess.
aterials and methods
acterial strains
hirty clinical isolates of P. aeruginosa and thirty
ound biopsy samples were retrieved from clin-
cal diagnostic laboratories in Khatam-al-Anbia
nd Shahid Motahari Hospitals (Tehran, Iran).
ll of these isolates were identiﬁed by conven-
ional biochemical and microscopic methods. P.
eruginosa (ATCC 27853) and non-P. aeruginosa
pecies, including Pseudomonas ﬂuorescens (ATCC
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Table 1 Primer sequences.
Target gene Nucleotide sequence Tm Amplicon size (bp)
lasI-F 5´-ATGATCGTACAAATTGGTCGG-3´ 66 ºC 600lasI-R 5´- GTCATGAAACCGCCAGTC-3´ 67 ºC
lasR-F 5´-ATGGCCTTGGTTGACGGT-3´ 65 ºC 700lasR-R 5´-GCAAGATCAGAGAGTAATAAGACCC-3´ 66 ºC
-3´
´
(
u
a
t
t
c
f
7
w
G
u
m
p
D
T
i
S
a
p
g
t
D
A
g
p
u
p
c
i
r
o
b
p
o
t
u
a
2gyrB-F 5´-CCTGACCATCCGTCGCCACAAC
gyrB-R 5´-CGCAGCAGGATGCCGACGCC-3
17386), Pseudomonas syringae (CCM 2868), Pseu-
domonas pertucinogena (ATCC 190), Pseudomonas
putida (ATCC 12633) and Burkholderia (Pseu-
domonas) cepacia, were received from the Iranian
Biological Resource Center (IBRC). Staphylococcus
aureus, Klebsiella pneumoniae, Escherichia coli
and Salmonella enteric serovar Typhimurium clin-
ical isolates (also received from Khatam-al-Anbia
and Shahid Motahari Hospitals) were used as con-
trols for the cross-reaction analyses.
DNA extraction
Genomic DNA was extracted using a DNA Pure
Extraction Kit (Bioneer, South Korea) according
to the manufacturer’s recommendations. Genomic
DNA of all of the clinical samples was also directly
extracted using MolYsis kit (Molzym, Germany). The
amount and purity of the extracted DNA was mea-
sured using a Nanodrop ND1000 spectrophotometer
(Thermo, USA).
Primer design
The sequences of the lasI, lasR genes were adopted
from GenBank accession number NC 002516.2. For-
ward and reverse primers (Table 1) were designed
using Oligo and DNAsis software. The las primers
were evaluated using the BLAST service to ensure
their speciﬁcity for P. aeruginosa. Speciﬁc primers
for the gyrB gene were the same as in Qin et al.
[27].
PCR ampliﬁcation with uniplex and triplex
assays
The PCR reaction for the ampliﬁcation of each gene
was performed as follows. Fifty microliter reactions
were prepared. Each reaction contained 5l of 10×
PCR buffer, 1.5mM MgCl2, 0.2mM of each dNTPNumber of copies = DNA
length (bp) ×65 ºC 22268 ºC
Ampliqon, Denmark), 20 pmol of each primer, 1
nit of Taq DNA polymerase (Ampliqon, Denmark),
nd 100 ng of DNA template. The reaction cycled
hrough the following temperature proﬁle: an ini-
ial denaturation at 95 ◦C for 5min, followed by 35
ycles of 95 ◦C for 30 s, 57 ◦C for 30 s, and 72 ◦C
or 30 s. Finally, the samples were subjected to
2 ◦C for 5min for ﬁnal extension. The PCR products
ere analyzed using %1 agarose gel electrophoresis.
eneRuler 100 bp DNA Ladder (Thermo, USA) was
sed to determine the size of the ampliﬁed frag-
ents. Triplex PCR was performed by combining the
rimers of all three genes in the same PCR reaction.
etermination of PCR speciﬁcity
o determine the speciﬁcity of the designed primers
n uniplex and triplex PCR assays, genomic DNA from
. aureus, K. pneumoniae, E. coli, S. typhimurium
nd non-P. aeruginosa species were used as tem-
lates. PCR reactions using lasI, lasR and gyrB
ene-speciﬁc primers were conducted under reac-
ion conditions, as stated before.
etermination of PCR sensitivity
fter preparation of a given concentration of
enomic DNA (100 ng/l), a serial dilution of sam-
les was prepared from 10−1 to 10−6 concentrations
sing sterile distilled water. PCR reactions were
erformed according to the previously mentioned
onditions. PCR test sensitivity in some studies
s evaluated based on the similarity between the
esults obtained from PCR assay and standard meth-
ds. In addition, the accuracy can be obtained
ased on the PCR results from the lowest DNA tem-
late dilution [13]. Alternatively, the sensitivity
f PCR could be determined based on the bac-
erial DNA copy numbers. For this purpose, we
sed the formula presented in the URI Genomics
nd Sequencing Center by Andrew Staroscik in
004.amount (ng) × 6.022 × 1023
1 × 109 (ng/g) × 650 (g/mole of bp)
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Statistical analysis
The statistical measures of sensitivity and speci-
ﬁcity were calculated through a comparison of the
bacterial culture (as the gold standard method) and
our new approach. To conﬁrm the accuracy of the
method, the PCR was performed three times for
each sample.
Results
PCR of lasI, lasR, and gyrB genes
The lasI, lasR, and gyrB genes were ampliﬁed from
the genomic DNA of standard P. aeruginosa, clinical
isolates and biopsy samples by uniplex and triplex
PCR. The produced amplicons were 600 bp, 700 bp,
and 222 bp for the lasI, lasR, and gyrB genes,
respectively. For all of the samples of P. aeruginosa,
the PCR results were positive (Figs. 1 and 2).
Figure 1 Uniplex and triplex PCR of P. aeruginosa. Lane
1: GeneRuler 100 bp DNA Ladder; Lane 2: gyrB ampli-
con (222 bp); Lane3: lasI amplicon (600 bp); Lane 4: lasR
amplicon (700 bp); Lane 5: triplex PCR for gyrB, lasI and
lasR genes of P. aeruginosa ATCC 27853; Lane 6: triplex
PCR without template.
Figure 2 Triplex PCR of clinical P. aeruginosa isolates.
Lane 1—3: triplex PCR of gyrB, lasI and lasR by DNA of
clinical isolates extracted from bacterial culture; Lane
3—6: triplex PCR of gyrB, lasI and lasR by DNA of wound
biopsy samples extracted using Kit; Lane 7: GeneRuler
100 bp DNA Ladder; Lane 8: PCR without template.
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wCR speciﬁcity for the lasI, lasR, and gyrB
enes
he genomic DNA of the S. aureus, K. pneumo-
iae, E. coli, S. typhimurium and non-P. aeruginosa
pecies were used as DNA templates to obtain the
peciﬁcity of the primers in PCR assays. The results
howed that the designed primers were speciﬁc to P.
eruginosa genes and that no amplicons were gen-
rated when the genome of another species was
sed (Table 2).
CR sensitivity for lasI, lasR, and gyrB genes
ecause the infectious dose of bacteria is the main
arameter in bacterial infections, it is important
hat the PCR assays be sensitive to the lowest
umber of this bacterium. Therefore, the genomic
NA of P. aeruginosa was extracted, and a serial
ilution from 100 ng to 100 fg/l was prepared.
ubsequently, uniplex PCR was performed for each
oncentration. In uniplex PCR, 10, 10 and 1 pg
f diluted DNA were the minimum concentra-
ions of genomic DNA that were detected for the
asI, lasR and gyrB genes amplicons, respectively
Fig. 3A—C). Additionally, in triplex PCR, the min-
mum concentration of detectable DNA was 10 pg
Fig. 3D). The sensitivity of the PCR was determined
ased on the bacterial DNA copy numbers. In this
tudy, according to the minimum concentration of
he DNA that can be visualized on the gel and the
ength of the bacterial genome (6264× 103 kbp),
he detectable copy number of bacterial DNA by the
asI, lasR and gyrB genes in uniplex PCR was 1000,
000, and 100, respectively, and in triplex PCR it
as 1000.
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Table 2 Determination of PCR speciﬁcity using genomic DNA of non-P. aeruginosa species and other bacteria as
PCR templates.
Bacterial Species
PCR Ampliﬁcaon*
lasI lasR gyrB
Pseudomonas aeruginosa + + +
Pseudomonas fluorescens - - -
Pseudomonas pertucinogena - - -
Pseudomonas syringae - - -
Burkholderia cepacia - - -
pseudomonas putida - - -
Staphylococcus aureus - - -
Klebsiella pneumoniae - - -
Escherichia coli - - -
Salmonella typhimurium - - -
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Statistical analysis
All of the positive and negative samples in the cul-
ture test had the same results in the PCR detection
procedure; therefore, the speciﬁcity and sensitiv-
ity of the detection of P. aeruginosa based on
lasI, lasR and gyrB gene ampliﬁcation is 100%. The
results obtained from repeating the steps did not
show any differences, and thus, lasI, lasR and gyrB
gene ampliﬁcation possesses a high accuracy in P.
aeruginosa detection.
Discussion
P. aeruginosa is one of the most extensive and seri-
ous factors in nosocomial infection. Van der Waaij
has shown that 10 to 100 cells of P. aeruginosa
can lead to gut colonization in immune-suppressed
patients who are in intensive care units [28]. Addi-
tionally, Ohman et al. and Hazlett et al. have
reported that 104 cells of P. aeruginosa per ml
can cause ocular infection in mice, and therefore,
early detection of this bacterium is critical [29,30].
Various methods have been developed for rapid
and accurate identiﬁcation of P. aeruginosa. Among
these methods, PCR, in comparison to the other
methods, has a lower cost and is highly accurate
and speciﬁc.
In 1992, for the ﬁrst time, the detection of P.
aeruginosa via the PCR method was reported by
McIntosh et al. They used the algD gene, which
encodes GDP mannose dehydrogenase, a major
M
a
cts.
nzyme in biosynthesis of alginate by P. aeruginosa
16]. They reported that P. aeruginosa could be
peciﬁcally detected with a precision of approxi-
ately 10 bacterial cells in sputum. In this study,
hey used a nested PCR method with two pairs of
rimers, but BLAST analysis of two primers (Pa1 and
a2) showed 88% and 100% sequence identity with
he algD gene of Azotobacter vinelandii. Studies
ave shown that the algD gene in this bacterium
as a high degree of identity (79%) at the DNA level
ith the algD gene from P. aeruginosa [31]. Khan
nd Cerniglia, in 1994, also used a PCR method,
hich was based on targeting and amplifying a 396-
p region of the exotoxin A (ETA) gene sequence
9]. The precision of the PCR assay was reported to
e 100% and 96%, respectively. According to their
eport, by targeting ETA, as few as 5—10 cells in
0-ml water samples or 0.1 pg of DNA per reaction
ixture (5l) could be detected. In 1997, De Vos
t al. evaluated the detection of P. aeruginosa by
riplex PCR using primers that were designed based
n two outer membrane lipoprotein genes, oprI and
prL. In this study, two amplicons, which were pro-
uced by the oprI and oprL genes, were observed
nly in P. aeruginosa isolates, while only the oprI
ene was ampliﬁed from the other pseudomonas
pecies. Likewise, the PCR results for all of the
ther bacteria were negative. The lowest detec-
ion level for P. aeruginosa was estimated to be
02 cells/ml [12]. On the other hand, similar to
cIntosh et al., Da Silva Filho and colleague [32]
lso evaluated the identiﬁcation of P. aeruginosa in
linical samples that were obtained from patients
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Figure 3 Sensitivity analysis of designed primers in uniplex (A: by lasI primers, B: by lasR primers, C: by gyrB primers)
and triplex PCR of P. aeruginosa (D). Lane 1: 100 bp ladder; Lane 2: non-diluted template; Lane 3: 1/10 dilution; Lane
4 0,00
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L: 1/100 dilution; Lane 5: 1/1000 dilution; Lane 6: 1/1
/1,000,000 dilution. For triplex PCR, the ﬁrst dilution is
ith cystic ﬁbrosis by PCR using primers for the algD
ene. In this study, the speciﬁcities of the primers
ere as high as 100%, and the method could detect
00 pg of bacterial DNA (good sensitivity). How-
ver, in comparison to new primers in our study,
hey show less sensitivity (10 pg of bacterial DNA
or our primers). It should be noted that based on
LAST analysis, the reverse primer in their study
s 100% identical to a part of the genome of Pseu-
omonas putida, and thus, it is not speciﬁc for
. aeruginosa.
From 2000 to 2011, many studies have been
eveloped to provide appropriate genes for the
dentiﬁcation of P. aeruginosa using speciﬁc primers
ith high sensitivity and speciﬁcity (Table 3).
ccording to these studies, targeting gyrB, toxA
nd transcribed 16S—23S rDNA internal transcribed
pacer (ITS) genes in PCR assays can dissociate P.
u
t
e0 dilution; Lane 7: 1/100,000 dilution; and Lane 8 (C):
0, which means that it has 10 ng of DNA template.
eruginosa from other species with 100% speciﬁcity
hile other genes, including 16S rDNA, oprL, oprI
nd ﬂiC, have lower speciﬁcity. Unspeciﬁc ampli-
cation was detected with 16SrDNA primers for
seudomonas fragi, oprL primers for Pseudomonas
alearica, and Pseudomonas citronellolis, oprI
rimers for Pseudomonas viridiﬂava, P. balearica,
nd P. citronellolis, and ﬁlC primers for all non-
. aeruginosa species, except for P. ﬂuorescens
nd P. citronellolis [13,21,33]. These false-positive
CR results show a high sequence conservation of
hese genes among pseudomonas species, which
an cause inoperative gene targeting for the detec-
ion of P. aeruginosa via PCR. On the other hand,
avenir et al. [13] have shown that the PCR assay
sing the toxA gene has PCR products for all of
he P. aeruginosa samples (100% speciﬁcity); how-
ver, similar to the Khan and Cerniglia results, the
320 H. Aghamollaei et al.
Table 3 Genes that were used for P. aeruginosa detection by uniplex and triplex PCR in previous studies.
Genes Production Reference
algD GDP-mannose dehydrogenase (McIntosh et al . 1992)
16S rDNA Ribosomal DNA sequence (O'Callaghan et al. 1994)
toxA Exotoxin A precursor (Khan and Cerniglia, 1994)
16s-23s rDNA Internal  
Transcribed Spacer (Tyler et al. 1995)
fliC C-terminus flagellin (Spangenberg et al. 1996)
oprI&oprL
Lipoprotein I &
outer-membrane peptidoglycan-
associated lipoprotein
(De Vos et al. 1997)
gyrB DNA gyrase subunit B (Qin et al. 2003)
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tecfX Extracytoplasmic fun(ECF) sigma factors
sensitivity was 95%. According to these studies, tar-
geting of the toxA gene for the identiﬁcation of P.
aeruginosa has an error of approximately 5%, which
can indicate its diversity. Because of the limita-
tions in the phenotypic methodologies, including
the biochemical tests, thus far, there has not been a
single test that could reliably identify P. aeruginosa.
Existing molecular assays also have speciﬁcity prob-
lems, which arise from the horizontal transfer of
P. aeruginosa genetic material to other Enterobac-
teriaceae species and variations in the genomic
DNA [19]. According to these studies, to decrease
the speciﬁcity problems in the identiﬁcation of
P. aeruginosa by PCR, the triplex assay is highly
suitable because a multi-target system evaluates
more than one factor simultaneously, which could
lead to the elimination of false-positive and nega-
tive results [12,19]. It is noteworthy that the early
detection of the bacterium using speciﬁc genes
plays a key role in the control of the infection.
Considering these points and given that the main
virulence factors that cause the pathogenicity of P.
aeruginosa are controlled by the quorum sensing
system genes, these genes are appropriate can-
didate targets in PCR assays. On the other hand,
several systematic studies on P. aeruginosa by trans-
criptional proﬁling experiments using microarrays
have demonstrated that QS is a global regulatory
network that controls the expression of over 300
genes by QS inducers [34]. Although the 16S ribo-
somal RNA (rRNA) gene is the most commonly used
gene for genetic identiﬁcation and characteriza-
tion of these bacteria, studies have shown that
the sequences of gyrB gene of P. aeruginosa and
other species of Pseudomonas revealed a higher
divergence than 16S rRNA genes. The reason is that
the gyrB gene rarely transmitted horizontally and
its molecular evolution rate is higher than that of
16S rRNA [21,35]. Therefore, the gyrB gene is a
p
t
t(Lavenir et al, 2007)
ore appropriate candidate target than 16S rRNA
or the identiﬁcation of the pseudomonas species.
owever, BLAST results for gyrB primers showed
hat the gyrB primer sequences designed by Qin
t al. [27] are 100% identical to the gyrB gene
rom Pseudomonas composti. This bacterium is a
ovel species that was reported in 2011 by Gibello
36]. The gyrB gene fragment of this strain has
99% identity to P. aeruginosa, and thus, it is
ossible to obtain false-positive results with gyrB
niplex PCR. Moreover, BLAST results showed that
esigned primers for the lasI and lasR genes have
complimentary region in all of the P. aeruginosa
trains and, in addition, have no similarity in non-P.
eruginosa species and other bacteria; therefore,
hey speciﬁcally detect only the P. aeruginosa
train. It should be noted that Pseudomonas species
ave similar quorum sensing system but the QS
enes in each species are unique and conserved
37].
In this study, in all of the samples, the target
equences were ampliﬁed, which was parallel with
he results of biochemical analyses and microbial
ultures. Based on these analyses, the sensitivity of
riplex PCR was high. Additionally in PCR reactions,
sing genomic DNA of non-P. aeruginosa species
nd other bacteria as templates, no false-positive
esults were observed, which demonstrates 100%
peciﬁcity. In uniplex PCR, the primer sensitivity
or the las gene was the same (10−4 DNA dilution),
hile the gyrB primers had the highest sensitivity
10−6 DNA dilution). In triplex PCR, the primer sen-
itivity was a 10−4 DNA dilution, which was similar
o lasI/R uniplex PCR assays. For the ﬁrst time, we
re reporting the detection of this bacterium via
he las and gyrB genes by a triplex PCR. In com-
arison to previous studies, these results showed
hat the selected genes are appropriate candidate
argets for epidemiological purposes and regional
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onitoring evaluation to achieve a common pattern
f the prevalence of P. aeruginosa.
Finally, it should be noted that in recent years,
uantitative PCR (qPCR) has been developed for
he detection of this bacterium [10,21,38,39].
lthough this type of PCR has advantages, such as
peed, throughput, sensitivity and lower amounts
f starting material, it also has some disadvantages,
ncluding the high cost of equipment, chemicals,
nd consumables and PCR inhibition [40]. In addi-
ion, due to its extremely high sensitivity, sound
xperimental design and normalization techniques
re imperative for accurate conclusions. Addition-
lly, in many laboratories, PCR in comparison to
PCR can be performed because it is a simple
ethod with widespread availability.
cknowledgments
he authors would like to thank all of the staff
f Applied Biotechnology Research Center for their
ind assistance.
eferences
[1] Driscoll JA, Brody SL, Kollef MH. The epidemiology,
pathogenesis and treatment of Pseudomonas aeruginosa
infections. Drugs 2007;67(3):351—68.
[2] Brown SP, Cornforth DM, Mideo N. Evolution of virulence in
opportunistic pathogens: generalism, plasticity, and con-
trol. Trends Microbiol 2012;20(7):336—42.
[3] Moghaddam MM, Abolhassani F, Babavalian H, Mirnejad R,
Barjini KA, Amani J. Comparison of in vitro antibacte-
rial activities of two cationic peptides CM15 and CM11
against ﬁve pathogenic bacteria: Pseudomonas aeruginosa,
Staphylococcus aureus, Vibrio cholerae, Acinetobacter
baumannii, and Escherichia coli. Probiotics Antimicrob Pro-
teins 2012;4(2):133—9.
[4] Obritsch MD, Fish DN, MacLaren R, Jung R. National
surveillance of antimicrobial resistance in Pseudomonas
aeruginosa isolates obtained from intensive care unit
patients from 1993 to 2002. Antimicrob Agents Chemother
2004;48(12):4606—10.
[5] Livermore DM. Multiple mechanisms of antimicrobial resis-
tance in Pseudomonas aeruginosa: our worst nightmare?
Clin Infect Dis 2002;34(5):634—40.
[6] Tam VH, Chang K-T, Abdelraouf K, Brioso CG, Ameka M,
McCaskey LA, et al. Prevalence, resistance mechanisms,
and susceptibility of multidrug-resistant bloodstream iso-
lates of Pseudomonas aeruginosa. Antimicrob Agents
Chemother 2010;54(3):1160—4.
[7] Zavascki AP, Carvalhaes CG, Picão RC, Gales AC. Multidrug-
resistant Pseudomonas aeruginosa and Acinetobacter
baumannii: resistance mechanisms and implications for
therapy. Expert Rev Anti Infect Ther 2010;8(1):71—93.[8] Mesaros N, Nordmann P, Plesiat P, Roussel-Delvallez M, Van
Eldere J, Glupczynski Y, et al. Pseudomonas aeruginosa:
resistance and therapeutic options at the turn of the new
millennium. Clin Microbiol Infect 2007;13(6):560—78.
[321
[9] Khan AA, Cerniglia CE. Detection of Pseudomonas
aeruginosa from clinical and environmental samples by
ampliﬁcation of the exotoxin A gene using PCR. Appl Environ
Microbiol 1994;60(10):3739—45.
10] Deschaght P, De Baere T, Van Simaey L, De Baets F, De
Vos D, Pirnay J-P, et al. Comparison of the sensitivity of
culture, PCR and quantitative real-time PCR for the detec-
tion of Pseudomonas aeruginosa in sputum of cystic ﬁbrosis
patients. BMC Microbiol 2009;9(1):244.
11] Clifford RJ, Milillo M, Prestwood J, Quintero R, Zurawski DV,
Kwak YI, et al. Detection of bacterial 16S rRNA and iden-
tiﬁcation of four clinically important bacteria by real-time
PCR. PLoS ONE 2012;7(11):e48558.
12] De Vos D, Lim A, Pirnay J-P, Struelens M, Vandenvelde
C, Duinslaeger L, et al. Direct detection and identiﬁca-
tion of Pseudomonas aeruginosa in clinical samples such as
skin biopsy specimens and expectorations by multiplex PCR
based on two outer membrane lipoprotein genes, oprI and
oprL. J Clin Microbiol 1997;35(6):1295—9.
13] Deschaght P, De Baets F, Vaneechoutte M. PCR and the
detection of Pseudomonas aeruginosa in respiratory sam-
ples of CF patients. A literature review. J Cyst Fibros
2011;10(5):293—7.
14] Tramper-Stranders G, Van der Ent C, Wolfs T. Detection of
Pseudomonas aeruginosa in patients with cystic ﬁbrosis. J
Cyst Fibros 2005;4:37—43.
15] Lavenir R, Jocktane D, Laurent F, Nazaret S, Cournoyer B.
Improved reliability of Pseudomonas aeruginosa PCR detec-
tion by the use of the species-speciﬁc ecfX gene target. J
Microbiol Methods 2007;70(1):20—9.
16] McIntosh I, Govan JR, Brock DJ. Detection of Pseu-
domonas aeruginosa in sputum from cystic ﬁbrosis patients
by the polymerase chain reaction. Mol Cell Probes
1992;6(4):299—304.
17] O’Callaghan E, Tanner M, Boulnois G. Development of a
PCR probe test for identifying Pseudomonas aeruginosa
and Pseudomonas (Burkholderia) cepacia. J Clin Pathol
1994;47(3):222—6.
18] Spangenberg C, Heuer T, Bürger C, Tümmler B. Genetic
diversity of ﬂagellins of Pseudomonas aeruginosa. FEBS Lett
1996;396(2):213—7.
19] Anuj SN, Whiley DM, Kidd TJ, Bell SC, Wainwright CE, Nis-
sen MD, et al. Identiﬁcation of Pseudomonas aeruginosa by
a duplex real-time polymerase chain reaction assay target-
ing the ecfX and the gyrB genes. Diagn Microbiol Infect Dis
2009;63(2):127—31.
20] Mathee K, Narasimhan G, Valdes C, Qiu X, Matewish
JM, Koehrsen M, et al. Dynamics of Pseudomonas
aeruginosa genome evolution. Proc Natl Acad Sci U S A
2008;105(8):3100—5.
21] Lee CS, Wetzel K, Buckley T, Wozniak D, Lee J. Rapid
and sensitive detection of Pseudomonas aeruginosa in
chlorinated water and aerosols targeting gyrB gene
using real-time PCR. J Appl Microbiol 2011;111(4):
893—903.
22] Girard G, Bloemberg GV. Central role of quorum sensing in
regulating the production of pathogenicity factors in Pseu-
domonas aeruginosa. Future Microbiol 2008;3:97—106.
23] Rutherford ST, Bassler BL. Bacterial quorum sensing: its role
in virulence and possibilities for its control. Cold Spring
Harb Perspect Med 2012;2(11):a012427.
24] Schuster M, Joseph Sexton D, Diggle SP, Peter Greenberg E.
Acyl-homoserine lactone quorum sensing: from evolution to
application. Annu Rev Microbiol 2013;67:43—63.
25] Antunes LCM, Ferreira RB, Buckner MM, Finlay BB.
Quorum sensing in bacterial virulence. Microbiology
2010;156(8):2271—82.
[[
[
[
[
[322
[26] Senturk S, Ulusoy S, Bosgelmez-Tinaz G, Yagci A. Quo-
rum sensing and virulence of Pseudomonas aeruginosa
during urinary tract infections. J Infect Dev Ctries
2012;6(06):501—7.
[27] Qin X, Emerson J, Stapp J, Stapp L, Abe P, Burns JL.
Use of real-time PCR with multiple targets to identify
Pseudomonas aeruginosa and other nonfermenting gram-
negative bacilli from patients with cystic ﬁbrosis. J Clin
Microbiol 2003;41(9):4312—7.
[28] Van der Waaij D. Colonization resistance of the digestive
tract: clinical consequences and implications. J Antimicrob
Chemother 1982;10(4):263—70.
[29] Hazlett L, Rosen D, Berk R. Age-related susceptibility to
Pseudomonas aeruginosa ocular infections in mice. Infect
Immun 1978;20(1):25—9.
[30] Ohman DE, Burns RP, Iglewski BH. Corneal infections in
mice with toxin A and elastase mutants of Pseudomonas
aeruginosa. J Infect Dis 1980;142(4):547—55.
[31] Campos M, Martinez-Salazar JM, Lloret L, Moreno S, Nún˜ez
C, Espín G, et al. Characterization of the gene coding
for GDP-mannose dehydrogenase (algD) from Azotobacter
vinelandii. J Bacteriol 1996;178(7):1793—9.
[32] da Silva Filho LV, Levi JE, Oda Bento CN, da Silva Ramos
SR, Rozov T. PCR identiﬁcation of Pseudomonas aeruginosa
and direct detection in clinical samples from cystic ﬁbrosis
patients. J Med Microbiol 1999;48(4):357—61.
[33] Tyler S, Strathdee C, Rozee K, Johnson W. Oligonu-
cleotide primers designed to differentiate pathogenic
[
Available online at www
ScienceDH. Aghamollaei et al.
pseudomonads on the basis of the sequencing of genes
coding for 16S—23S rRNA internal transcribed spacers. Clin
Diagn Lab Immunol 1995;2(4):448—53.
34] Smith RS, Iglewski BH. Pseudomonas aeruginosa quorum
sensing as a potential antimicrobial target. J Clin Invest
2003;112(10):1460—5.
35] Anzai Y, Kim H, Park J-Y, Wakabayashi H, Oyaizu H.
Phylogenetic afﬁliation of the pseudomonads based on
16S rRNA sequence. Int J Syst Evol Microbiol 2000;50(4):
1563—89.
36] Gibello A, Vela AI, Martín M, Mengs G, Alonso PZ, Garbi
C, et al. Pseudomonas composti sp. nov., isolated from
compost samples. Int J Syst Evol Microbiol 2011;61(12):
2962—6.
37] Venturi V. Regulation of quorum sensing in Pseudomonas.
FEMS Microbiol Rev 2006;30(2):274—91.
38] Pirnay J-P, De Vos D, Duinslaeger L, Reper P, Vanden-
velde C, Cornelis P, et al. Quantitation of Pseudomonas
aeruginosa in wound biopsy samples: from bacterial cul-
ture to rapid ‘real-time’ polymerase chain reaction. Crit
Care 2000;4(4):255—61.
39] Le Gall F, Le Berre R, Rosec S, Hardy J, Gouriou S,
Boisramé-Gastrin S, et al. Proposal of a quantitative PCR-
based protocol for an optimal Pseudomonas aeruginosa
detection in patients with cystic ﬁbrosis. BMC Microbiol
2013;13(1):143.
40] Wong ML, Medrano JF. Real-time PCR for mRNA quantita-
tion. Biotechniques 2005;39(1):75.
.sciencedirect.com
irect
